staurosporine has been researched along with Fetal Growth Retardation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ojha, S; Ooi, MG | 1 |
Bryant-Greenwood, G; Büllesbach, E; Kawamata, T; Millar, L; Okabe, R; Schwabe, C; Shimoda, J; Streiner, N; Webster, L; Yamamoto, S | 1 |
2 other study(ies) available for staurosporine and Fetal Growth Retardation
Article | Year |
---|---|
Pregnancy exposure to midostaurin in the first trimester.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Compassionate Use Trials; Cytarabine; Female; Fetal Growth Retardation; fms-Like Tyrosine Kinase 3; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Leukemia, Myeloid, Acute; Mutation; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, First; Protein Kinase Inhibitors; Recurrence; Staurosporine; Tandem Repeat Sequences | 2020 |
Early placental insulin-like protein (INSL4 or EPIL) in placental and fetal membrane growth.
Topics: Amnion; Apoptosis; Cell Membrane; Cells, Cultured; Extraembryonic Membranes; Female; Fetal Growth Retardation; Gene Expression Regulation, Developmental; Humans; Intercellular Signaling Peptides and Proteins; Placenta; Pregnancy; Reference Values; Relaxin; Staurosporine; Twins | 2005 |